Psoralen and bergapten
StrongMechanism of Action
Research Notes
The phototoxic mechanism of furanocoumarins is extensively characterized (Pathak et al., 1974). Psoralen-UVA (PUVA) therapy has been used clinically since the 1970s for psoriasis, vitiligo, and cutaneous T-cell lymphoma with well-established efficacy in multiple large RCTs. The International Agency for Research on Cancer (IARC) classifies psoralen plus UVA as a Group 1 carcinogen with long-term therapeutic use. Case reports of phytophotodermatitis from rue are well documented in dermatology literature.
Found In 1 Herb
3D Molecular Structure
Psoralen and bergapten
Representative pattern: C₇H₆O₃
Related Compounds (Furanocoumarin)
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
